Obesity-Linked Gaps in Pulmonary Embolism Management – Shared by Zain Khalpey
Zain Khalpey, Chief Medical AI Officer, Chair of Applied Clinical AI, Director, Khalpey AI Lab at ATARI AI, posted on LinkedIn:
”Obesity changes everything about pulmonary embolism from diagnosis to drug dosing.
This new JACC review highlights how body size complicates imaging accuracy, influences anticoagulant and interventional choices, and even shapes outcomes through the “obesity paradox.”
The takeaway is clear: one size fits all guidance doesn’t work.
We need pragmatic, obesity-aware protocols and updated guidelines that reflect real world patients.
Full review here.
Follow Zain Khalpey for more on AI and Healthcare.”
Title: Obesity and Acute Pulmonary Embolism: Clinical Implications and Knowledge Gaps
Authors: Marco Zuin, Gregory Piazza, Stefano Barco, Laurent Bertoletti, Michal Ciurzynski, Nika Skoro-Sajer, Marcin Kurzyna, Sophia Anastasia Mouratoglou, Lukas Hobohm, Frederikus A. Klok
Keep up with Hemostasis Today.
-
Dec 16, 2025, 16:56Kathryn Mikkelsen on The Beat: Vasculearn Network’s Newsletter for Clot Survivors
-
Dec 16, 2025, 16:50Raul Santos on Sex-Specific Biology and Plasma Fructose Levels in Cardiovascular Risk
-
Dec 16, 2025, 16:34Mads Krogsgaard Thomsen on Novo Nordisk Haemophilia Foundation’s Support for Haemoglobinopathies
-
Dec 16, 2025, 16:22Leonardo Furtado Freitas Presents a Rare Hemorrhagic Hemangioblastoma Case
-
Dec 16, 2025, 16:14Nicolas Gendron on Sustainability in Anticoagulation and DOACs
-
Dec 16, 2025, 15:39Reza Shojaei: Every Expired Unit of Blood Tells a Story
-
Dec 16, 2025, 14:03Francesco Lo Monaco on Rethinking Blood Pressure: The Major Problem with How We Understand It
-
Dec 16, 2025, 14:03Marilena Vrana Urges EU Policymakers to “Keep Patients at the Centre” of Critical Medicines Act
-
Dec 16, 2025, 14:02Even Distribution of Protective Hemoglobin Prevents Sickle Cell Symptoms